Aggressive sino-nasal non-Hodgkin's lymphoma diagnosed in Nottinghamshire, UK, between 1987 and 1996

被引:0
作者
Quraishi, MS
Bessell, EM
Clark, DM
Jones, NS
Bradley, PJ
机构
[1] City Hosp Nottingham, Dept Clin Oncol, Nottingham NG5 1PB, England
[2] Univ Nottingham Hosp, Nottingham NG7 2UH, England
关键词
chemotherapy; lymphoma; nasal cavity; paranasal sinuses; radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the 10-year period 1987 to 1996, 24 patients were diagnosed with aggressive non-Hodgkin's lymphoma of the nasal cavities or paranasal sinuses. The disease occurred in a relatively elderly population of median age 72 years (range 42 to 96) with a male predominance (male 15; female nine). The histology on review was mostly of the large B-cell subtype (21 patients); peripheral T-cell subtype (one), anaplastic large cell of T-cell type (one) and T/natural killer cell nasal lymphoma (one). The disease was localized in 20 patients (Stage I(E)A). The overall survival at 5 years was 40% (95% confidence interval (CI) 19-61); at 10 years it was 33% (95% CI 12-54). The cause-specific survival (excluding deaths from causes other than lymphoma) at 5 years and 10 years was 62% (95% CI 39-86).
引用
收藏
页码:269 / 272
页数:4
相关论文
共 50 条
[41]   Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): Results of prospective study with multimodality therapeutic approach [J].
De Sanctis, V ;
Martelli, M ;
Anticoli, AP ;
Caronna, R ;
Chirletti, P ;
Giovannini, M ;
Santarelli, M ;
Enrici, RM ;
Mandelli, F .
ANTICANCER RESEARCH, 2001, 21 (6A) :4169-4172
[42]   FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management [J].
Pelosi, E. ;
Penna, D. ;
Deandreis, D. ;
Chiappella, A. ;
Skanjeti, A. ;
Vitolo, U. ;
Bisi, G. .
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (01) :9-16
[43]   Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: A survey of the Japan Lymphoma Radiation Therapy Group [J].
Oguchi, M ;
Ikeda, H ;
Isobe, K ;
Hirota, S ;
Hasegawa, M ;
Nakamura, K ;
Sasai, K ;
Hayabuchi, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :161-168
[44]   Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993–1996 [J].
D. J. van Spronsen ;
M. L. G. Janssen-Heijnen ;
W. P. M. Breed ;
J. W. W. Coebergh ;
D. J. van Spronsen .
Annals of Hematology, 1999, 78 :315-319
[45]   Relationships between dose or dose intensity and efficacy of chemotherapy in adult aggressive non-Hodgkin's lymphomas [J].
Solal-Celigny, P ;
Colombat, P .
BULLETIN DU CANCER, 1998, 85 (03) :232-238
[46]   Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups [J].
Reem Ameen ;
Kamlesh P. Sajnani ;
Amani Albassami ;
Samar Refaat .
Annals of Hematology, 2010, 89 :179-184
[47]   Frequencies of non-Hodgkin's lymphoma subtypes in Kuwait: comparisons between different ethnic groups [J].
Ameen, Reem ;
Sajnani, Kamlesh P. ;
Albassami, Amani ;
Refaat, Samar .
ANNALS OF HEMATOLOGY, 2010, 89 (02) :179-184
[48]   High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis [J].
Azim, H. A. ;
Santoro, L. ;
Bociek, R. G. ;
Gandini, S. ;
Malek, R. A. ;
Azim, H. A., Jr. .
ANNALS OF ONCOLOGY, 2010, 21 (05) :1064-1071
[49]   Aggressive non-Hodgkin's lymphoma: Long term results of full dose CHOP chemotherapy, and analysis of prognostic determinant [J].
Bezwoda, WR ;
Dansey, R .
LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) :303-310
[50]   Prognostic significance of circulating plasma Epstein-Barr virus DNA in monitoring aggressive non-Hodgkin's lymphoma [J].
An, Na ;
Xie, Yaping ;
Shi, Pengfei ;
Xu, Ying ;
Qian, Shenxian .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04) :6837-6844